HomeCLYM • NASDAQ
add
Climb Bio Inc
Previous close
$4.38
Day range
$4.13 - $4.63
Year range
$1.05 - $4.82
Market cap
291.83M USD
Avg Volume
1.72M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.89M | 26.93% |
Net income | -12.89M | -44.89% |
Net profit margin | — | — |
Earnings per share | -0.19 | — |
EBITDA | -14.86M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.90M | -55.06% |
Total assets | 182.30M | -17.95% |
Total liabilities | 5.30M | 54.86% |
Total equity | 177.00M | — |
Shares outstanding | 68.18M | — |
Price to book | 1.68 | — |
Return on assets | -19.87% | — |
Return on capital | -20.46% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -12.89M | -44.89% |
Cash from operations | -12.14M | -60.68% |
Cash from investing | 15.26M | 121.26% |
Cash from financing | — | — |
Net change in cash | 3.12M | 104.06% |
Free cash flow | -8.06M | -32.29% |
About
Founded
2018
Headquarters
Website
Employees
18
